¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"inflammatory scoliosis"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 1
¿µ¹® scoliosis ÇÑ±Û Ã´ÁÖ¿·±ÁÀ½Áõ, ôÁÖÃø¸¸Áõ
¼³¸í   
  Ã´ÁÖ°¡ ¿·À¸·Î ±Á¾îÁø º¯Çü. ¿øÀκҸíÀǠƯ¹ß¼º ¿·±ÁÀ½Áõ°ú ¿øÀÎÀÌ È®½ÇÇÑ ÁõÈļº ¿·±ÁÀ½ÁõÀ¸·Î ³ª´¶´Ù. Æ¯¹ß¼º ¿·±ÁÀ½ÁõÀÌ Áõ·ÊÀÇ ´ëºÎºÐÀ» Â÷ÁöÇϸç, ¹ßº´ ¿¬·É¿¡ µû¶ó ¿µÀ¯¾Æ±â, ÃʵîÇлý±â, »çÃá±â·Î ºÐ·ùµÇ´Âµ¥, ´ëºÎºÐÀº »çÃá±â¼ºÀÌ´Ù. Ä¡·á´Â ±â±¸¿ä¹ý µîÀÇ º¸Á¸¿ä¹ýÀÌ ±âº»ÀÌÁö¸¸, ÁøÇ༺ÀΠ°Í, È£Èí±â´ÉÀå¾Ö³ª ½Å°æÇÕº´ÁõÀÌ Àִ °Í, º¸Àü¿ä¹ýÀ¸·Î Ä¡·á°¡ µÇÁö ¾Ê´Â °Í µî¿¡´Â ¼ö¼úÀû¿ä¹ýÀÌ ÇàÇØÁø´Ù. Áõ»óÀº ¸ñÀÌ Á¿ì·Î ¿òÁ÷À̴ ¾çÀÌ ´Ù¸£°í, ÇÑÂʾî±ú°¡ ´Ù¸¥ ÂÊ ¾î±úº¸´Ù ³ôÀºµ¥ ¾ûµ¢À̴ ¹Ý´ëÂÊÀÌ ³ô´Ù. ³²¼ºº¸´Ù ¿©¼º¿¡ ¸¹ÀÌ ³ªÅ¸³ª¸ç ÁַΠ10~15¼¼ »çÀÌ ¿©Çлý¿¡°Ô ¸¹ÀÌ ¹ß»ýÇÑ´Ù. ºü¸¥ ¼Óµµ·Î ÁøÇàÇϱ⠶§¹®¿¡ ÀǽÉÀÌ °¡¸é °Ë»ç¸¦ Çϴ °ÍÀÌ ÁÁ´Ù. Ã´ÃßÃø¸¸ÁõÀº Å©°Ô ±â´É¼º°ú ±¸Á¶¼ºÀ¸·Î ³ª´­ ¼ö ÀÖ´Ù. ±â´É¼º ¶Ç´Â ºñ±¸Á¶¼º Ã´ÃßÃø¸¸ÁõÀº Ã´Ãß ÀÚü¿¡´Â ¹®Á¦°¡ ¾øÁö¸¸ ´Ù¸¥ ¿ÜºÎÀÇ ¿øÀÎÀ¸·Î Áõ¼¼°¡ ¹ß»ýÇÏ¿© 2Â÷ÀûÀΠÁõ¼¼·Î ³ªÅ¸³ª´Â °ÍÀ» ¸»ÇÑ´Ù. ÀÇÀÚ¿¡ ¾É´Â ÀÚ¼¼°¡ ¹Ù¸£Áö ¸øÇÑ °æ¿ì³ª Ã¥°¡¹æÀ» ÇÑ ÂÊÀ¸·Î¸¸ µé°í ´Ù´Ï´Â °æ¿ì¿¡ ¹ß»ýÇϴ °ÍÀ¸·Î ¾Ë·ÁÁ® ÀÖ´Ù. ÀÌ ¹Û¿¡µµ ´Ù¸® ±æÀ̰¡ ´Þ¶ó¼­ ¹ß»ýÇϴ °æ¿ì, ¾ûµ¢°üÀýÀÌ ±»¾î¼­ ³ªÅ¸³ª´Â °æ¿ì, Ç㸮 Ã´Ãß¿ø¹ÝÅ»ÃâÀ̳ª Ã´ÃßÀÇ ¾ç¼ºÁ¾¾çÀ¸·Î ¹ß»ýÇϴ °æ¿ìµµ ÀÖ´Ù. ±â´É¼º Ãø¸¸ÁõÀÇ °æ¿ì¿¡´Â ±× ¿øÀθ¸ Á¦°ÅÇϸé Áõ¼¼°¡ »ç¶óÁø´Ù. ±¸Á¶¼º Ã´ÃßÃø¸¸ÁõÀº Ã´Ãß ÀÚüÀÇ ¹®Á¦·Î ÀÎÇÏ¿© ¹ß»ýÇϸç, ´ëºÎºÐÀÇ °æ¿ì ¾ÆÁ÷ ¿øÀÎÀÌ ¾Ë·ÁÁ® ÀÖÁö ¾Ê´Ù. À̴ »çÃá±â ÀÌÀü¿¡ ¹ß»ýÇϴµ¥, ¿©Çлý¿¡°Ô Æ¯È÷ ½ÉÇϰԠ³ªÅ¸³¯ ¼ö ÀÖ´Ù. À̠ôÃßÃø¸¸ÁõÀº ³ú¼º¸¶ºñ, ±ÙÀ°¸¶ºñ, ¼Ò¾Æ¸¶ºñ, ¼±Ãµ¼º Ã´Ãß ÀÌ»ó µî¿¡ ÀÇÇÏ¿© ³ªÅ¸³ª±âµµ ÇÑ´Ù. ±× ¹Û¿¡ ¼±Ãµ¼º Ã´ÃßÃø¸¸ÁõÀº °¡Á· ÁßÀÇ ÇÑ ¸íÀ̠ôÃßÃø¸¸ÁõÀÌ ÀÖÀ» °æ¿ì ¹ß»ý·üÀº 20% Á¤µµ·Î ÀϹÝÀûÀΠ¹ß»ý·ü 2%¿¡ ºñÇÏ¿© ³ô´Ù. ÀÌ °æ¿ì¿¡´Â ½Åü ´Ù¸¥ Àå±âÀÇ ±âÇüÀ» Àß µ¿¹ÝÇϴµ¥, ºñ´¢±âÀû ±âÇüÀÇ 20~40%, ½ÉÀå ±âÇüÀÇ 10~20%, Ã´Ã߽Űæ ÀÌ»óÀÇ 10~40%¸¦ µ¿¹ÝÇÒ ¼ö ÀÖÀ¸¹Ç·Î ÀÌ·¯ÇÑ µ¿¹Ý ±âÇü¿¡ ´ëÇØ¼­µµ ÃÊÀ½ÆÄ °Ë»ç, ÄáÆÏ°Ë»ç µîÀÌ ÇÊ¿äÇÏ´Ù.
¿µ¹® pelvic inflammatory disease ÇÑ±Û °ñ¹Ý¿°Áúȯ
¼³¸í   
  °ñ¹ÝÁÖÀ§ÀÇ Àå±â¿¡ ¹ß»ýÇϴ ¿°ÁõÀ» ¸»ÇÔ. ÁַΠ¿©¼º¿¡¼­ ¹ß»ýÇϸ砿øÀÎÀº ÀÓ±Õ(gonococcus)°ú ºñÀÓ±Õ¿¡ ÀÇÇÑ °¨¿°(non-gonorrheal infection)¿¡ ÀÇÇÑ´Ù. Áõ»óÀº Ãʱ⿡´Â ÁúºÐºñ¹°, ÇϺ¹ºÎµ¿Åë, ¿©¼ºÀÇ »ý½Ä±âºÎÀ§¿¡ ¹ß»ýÇϴ ¾ÐÅë, ¿ù°æÅë, ¿ù°æ·®ÀÇ Áõ°¡ µîÀÌ´Ù. ÀÏÂï Ä¡·áÇØ¾ß Çϸç, °è¼ÓÀûÀ¸·Î º´ÀÌ Áö¼Ó½Ã ¿©¼ºÀÇ ºÒÀÓÀÇ ¿øÀÎÀÌ µÈ´Ù. ÈÄÁø±¹¿¡¼­´Â °¡Àå ¸¹Àº ¿©¼ººÒÀÓÀÇ ¿øÀÎÀ̱⵵ ÇÔ. Ä¡·á´Â Ç×»ýÁ¦ÀÇ Åõ¿©ÀÌ´Ù.
¿µ¹® inflammatory bowel disease ÇÑ±Û ¿°Áõ¼ºÃ¢ÀÚº´
¼³¸í   
  À§Àå°üÀ» Ä§¹üÇϴ Á¤È®ÇÑ ¿øÀÎÀÌ ¹àÇôÁöÁö ¾ÊÀº ¸¸¼ºÀûÀΠ¿°Áõ¼º ÁúȯÀ» ¸»ÇÑ´Ù. Å©°Ô ¡®±Ë¾ç¼º ´ëÀå¿°¡¯(ulcerative colitis)°ú ¡®Å©·Ðº´¡¯(Crohn's disease)ÀÇ µÎ Á¾·ù·Î ±¸ºÐµÈ´Ù. ¹éÀÎ, À¯ÅÂÀο¡ ¸¹°í ÈæÀÎÀ̳ª µ¿¾çÀο¡´Â µå¹°Áö¸¸ µ¿¾çÀο¡¼­ Á¡Â÷ Áõ°¡Ãß¼¼¿¡ ÀÖ´Ù. È£¹ß¿¬·ÉÀº 15~35¼¼ »çÀÌÀÌ´Ù. Áõ»óÀº ¡®±Ë¾ç¼º ´ëÀå¿°¡¯ÀÇ °æ¿ì, ¼³»ç(Ç÷º¯ ¹× Á¡¾×º¯), µÚ¹«Á÷, º¹Åë, º¹ºÎ¾ÐÅë, Ã¼Áß°¨¼Ò µîÀÌ ÁַΠ³ªÅ¸³ª¸ç ¡®Å©·Ðº´¡¯¿¡¼­´Â ¼³»ç¿Í Ã¼Áß°¨¼Ò, ¿ìÇϺ¹ºÎ Á¾·ù, Ç×¹®ÁÖÀ§ ÀÌ»ó, º¹ºÎ¾ÐÅë µîÀÌ ³ªÅ¸³­´Ù. Áø´ÜÀº º´·Â°ú ¹æ»ç¼±ÇÐÀû °Ë»ç, Á÷Àå°æ ¹× ´ëÀå ³»½Ã°æ°Ë»ç, Á÷Àå ¹× ´ëÀåÀÇ Á¶Á÷°Ë»ç·Î Çϸç Ä¡·á´Â ³»°úÀûÀΠġ·á°¡ ¿øÄ¢À̳ª ³»°úÀû Ä¡·á¿¡ µèÁö ¾Ê°Å³ª ÇÕº´ÁõÀÌ »ý±æ °æ¿ì¿¡´Â ¿Ü°úÀû Ä¡·á¸¦ ½ÃÇàÇÑ´Ù. ¡®±Ë¾ç¼º ´ëÀå¿°¡¯ÀÇ °æ¿ì¿¡´Â ¡®´ëÀå¾Ï¡¯À» ¿¹¹æÇϱâ À§Çؼ­ ¿Ü°úÀû Ä¡·á¸¦ Çϱ⵵ ÇÑ´Ù. ¡®±Ë¾ç¼º ´ëÀå¿°¡¯°ú ¡®Å©·Ð º´¡¯¿Ü¿¡ ¿°Áõ¼º Ã¢ÀÚº´¿¡ ¼ÓÇϴ ¡®º£Ã¼Æ® º´¡¯Àº Àç¹ß¼º ±¸°­³» ±Ë¾ç, ÇǺΠº´º¯, ¾È±¸ºÎ ¿°Áõ, ¿ÜÀ½ºÎ ±Ë¾ç, °üÀý¿° Áõ»ó, À§Ã¢ÀÚ°ü Áõ»ó(º¹Åë, ÀåÃâÇ÷), ºÎ°íȯ¿° µîÀÇ Áõ»óÀ» ³ªÅ¸³»´Âµ¥ Áø´Ü°ú Ä¡·á´Â ¡®±Ë¾ç¼º ´ëÀå¿°¡¯, ¡®Å©·Ð º´¡¯°ú ºñ½ÁÇÏ´Ù.
¿µ¹® anti-inflammatory agent ÇÑ±Û Ç׿°ÁõÁ¦, ¼Ò¿°Á¦, ¿°Áõ¾à
¼³¸í   
  ±¹¼Ò¿¡ ÀÛ¿ëÇÏ¿© ¿°ÁõÀ» Ä¡·áÇÏ°í ¹æÁöÇϴ ¾à. ¿°ÁõÀ» °¡¶ó¾ÉÈ÷´Â ¾àÀ» ¸»ÇÑ´Ù. Á¶Á÷À» ±äÃà-Ä¡¹ÐÇϰԠÇÏ¿© Àå¾×°ú Á¡¾×ÀÇ ºÐºñ¸¦ ÁÙÀ̰í, Ç¥¸é¿¡ Àִ ÀÛÀº Ç÷°ü¿¡ ºóÇ÷À» ÀÏÀ¸ÄÑ ÃæÇ÷µÇ´Â °ÍÀ» ¹æÁöÇÔÀ¸·Î½á ¿°ÁõÀû º´º¯À» Á¦°ÅÇÏ¿© ¸ðµç Áõ¼¼¸¦ ¾ø¾Ø´Ù. ´ëºÎºÐÀÇ ¼ö·ÅÁ¦-¿ÏÈ­Á¦-Áø¾çÁ¦°¡ ÀÌ¿¡ ¼ÓÇÑ´Ù. Áß¿äÇÑ ¼ººÐÀ¸·Î´Â ¾Ë·ç¹Ì´½-ºñ½º¹«Æ®-¾Æ¿¬-³³È­ÇÕ¹°(º´¹Ý-Æä¸£¸¶Åç-¾Æ¿¬È­-¿¬´ç µî) µîÀÌ ÀÖ´Ù. ÀÛ¿ë¿¡ µû¶ó Ç׿°ÁõÁøÅëÁ¦¿Í Ç׿°ÁõÈ¿¼ÒÁ¦·Î ³ª´¶´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • alternating scoliosis
    ±³´ëôÁÖ¿·±ÁÀ½Áõ, ±³´ëôÁÖÃø¸¸Áõ
  • functional scoliosis
    ±â´É¼ºÃ´ÁÖ¿·±ÁÀ½Áõ, ±â´É¼ºÃ´ÁÖÃø¸¸Áõ
  • habitual scoliosis
    ½À°ü¼ºÃ´ÁÖ¿·±ÁÀ½Áõ, ½À°ü¼ºÃ´ÁÖÃø¸¸Áõ
  • myopathic scoliosis
    ±Ù(À°)º´Ã´ÁÖ¿·±ÁÀ½Áõ, ±Ù(À°)º´Ã´ÁÖÃø¸¸Áõ
  • organic scoliosis
    ±âÁú¼ºÃ´ÁÖ¿·±ÁÀ½Áõ, ±âÁú¼ºÃ´ÁÖÃø¸¸Áõ
  • paralytic scoliosis
    ¸¶ºñôÁÖ¿·±ÁÀ½Áõ, ¸¶ºñôÁÖÃø¸¸Áõ
  • rachitic scoliosis
    ±¸·çº´Ã´ÁÖÃø¸¸Áõ
  • rheumatic scoliosis
    ·ù¸¶Æ¼½ºÃ´ÁÖÃø¸¸Áõ
  • static scoliosis
    ´Ù¸®Â÷ÀÌôÁÖ¿·±ÁÀ½Áõ, ÇÏÁöºÎµ¿Ã´ÁÖÃø¸¸Áõ
  • scoliosis
    ôÁÖ¿·±ÁÀ½Áõ, ôÁÖÃø¸¸Áõ
  • inflammatory
    ¿°Áõ-
  • inflammatory bowel disease
    ¿°ÁõâÀÚÁúȯ, ¿°Áõ¼ºÀåÁúȯ
  • inflammatory carcinoma
    ¿°ÁõÇü¾ÏÁ¾
  • inflammatory cell
    ¿°Áõ¼¼Æ÷
  • inflammatory diarrhea
    ¿°Áõ¼³»ç
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 11 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • scoliosis
    ôÁÖ¿·±ÁÀ½Áõ, ôÁÖÃø¸¸Áõ
  • anti-inflammatory agent
    Ç׿°ÁõÁ¦, ¼Ò¿°Á¦, ¿°Áõ¾à
  • inflammatory cell
    ¿°Áõ¼¼Æ÷
  • inflammatory breast cancer
    ¿°ÁõÀ¯¹æ¾Ï
  • inflammatory bowel disease
    ¿°ÁõâÀÚÁúȯ
  • pelvic inflammatory disease
    °ñ¹Ý³»°¨¿°
  • inflammatory endometrium
    ¿°ÁõÀڱ󻸷, ¿°ÁõÀڱüӸ·
  • inflammatory
    ¿°Áõ-
  • inflammatory mediator
    ¿°Áõ¸Å°³Ã¼
  • inflammatory response
    ¿°Áõ¹ÝÀÀ
  • systemic inflammatory response syndrome
    Àü½Å¿°Áõ¹ÝÀÀÁõÈıº
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • alternating scoliosis
    ±³´ëôÁÖ¿·±ÁÀ½Áõ, ±³´ëôÁÖ¸¸°îÁõ
  • chiatic scoliosis
    ±ÃµÕ»ÀôÁÖ¿·±ÁÀ½Áõ, Á°ñôÁÖ¿·±ÁÀ½Áõ
  • dorsal scoliosis
    µîÂÊôÁÖ¿·±ÁÀ½Áõ, µîÂÊôÁÖÃø¸¸Áõ
  • functional scoliosis
    ±â´ÉôÁÖ¿·±ÁÀ½Áõ, ±â´ÉôÁÖÃø¸¸Áõ
  • habitual scoliosis
    ½À°üôÁÖ¿·±ÁÀ½Áõ, ½À°üôÁÖÃø¸¸Áõ
  • myopathic scoliosis
    ±ÙÀ°º´Ã´ÁÖ¿·±ÁÀ½Áõ, ±ÙÀ°º´Ã´ÁÖÃø¸¸Áõ
  • organic scoliosis
    ±âÁúôÁÖ¿·±ÁÀ½Áõ, ±âÁúôÁÖÃø¸¸Áõ
  • paralytic scoliosis
    ¸¶ºñôÁÖ¿·±ÁÀ½Áõ, ¸¶ºñôÁÖÃø¸¸Áõ
  • rachitic scoliosis
    ±¸·íº´Ã´ÁÖ¿·±ÁÀ½Áõ, ±¸·íº´Ãø¸¸Áõ
  • rheumatic scoliosis
    ·ù¸¶Æ¼½ºÃ´ÁÖ¿·±ÁÀ½Áõ, ·ù¸¶Æ¼½ºÃø¸¸Áõ
  • scoliosis
    ôÁÖ¿·±ÁÀ½Áõ, ôÁÖÃø¸¸Áõ
  • static scoliosis
    ¹ß±æÀÌÂ÷ÀÌôÁÖ¿·±ÁÀ½Áõ, ¹ß±æÀÌÂ÷ÀÌôÁÖÃø¸¸Áõ
  • anti-inflammatory agent
    Ç׿°ÁõÁ¦, ¼Ò¿°Á¦, ¿°Áõ¾à
  • cervical inflammatory ectropion
    ¿°ÁõÀڱøñ¿Ü¹øÁõ, ¿°Áõ°æ°ü¿Ü¹øÁõ
  • inflammatory carcinoma
    ¿°Áõ¾ÏÁ¾
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 10 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Inflammatory response
    ¿°Áõ¹ÝÀÀ(æúñøÚãëë)
  • acute inflammatory demyeliniating
    ±Þ¼º¿°Áõ¼ºÅ»¼öÃʼº(¡­æúñøàõ ÷­âÐÃÊàõ)
  • alternating scoliosis
    ±³´ë Ãø¸¸Áõ(ÎßÓÛö°Ø¶ñø), ±³¹øÃ´Ã߸¸°î(ÎßÛãô±õÐØ¶ÍØ).
  • anti-inflammatory
    Ç׿°Áõ¼º(ù÷æúñøàõ)ÀÇ.
  • anti-inflammatory
    Ç׿°(Áõ)¼º
  • anti-inflammatory agent
    Ç׿°Áõ¾à(ù÷æúñøå·).
  • habitual scoliosis
    ½À°ü¼º (ôÁÖ)Ãø¸¸Áõ(ã§Î±àõ ô±ñº ö°Ø¶ñø).
  • habitual scoliosis
    ½À°ü¼º (ôÁÖ)Ãø¸¸Áõ(¡­ô±ñºö°Ø¶ñø).
  • rachitic scoliosis
    ±¸·çº´¼º Ãø¸¸( ×§Ü»àõ ö°Ø¶).
  • rachitic scoliosis
    ±¸·çº´¼º Ãø¸¸(±¸×§Ü»àõ ö°Ø¶)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • alternating scoliosis
    ±³´ë Ãø¸¸Áõ(ÎßÓÛö°Ø¶ñø), ±³¹øÃ´Ã߸¸°î(ÎßÛãô±õÐØ¶ÍØ).
  • dorsal scoliosis
    Èä(ºÎ)Ãø¸¸(Áõ)(ýØÝ»ö°Ø¶ñø).
  • functional scoliosis
    ±â´É¼º (ôÃß)Ãø¸¸(Áõ)(¡­àõô±õÐö°Ø¶ñø).
  • habit scoliosis
    ½À°ü¼º (ôÁÖ)Ãø¸¸Áõ(¡­ô±ñºö°Ø¶ñø).
  • habitual scoliosis
    ½À°ü¼º (ôÁÖ)Ãø¸¸Áõ(ã§Î±àõ ô±ñº ö°Ø¶ñø).
  • habitual scoliosis
    ½À°ü¼º (ôÁÖ)Ãø¸¸Áõ(¡­ô±ñºö°Ø¶ñø).
  • ischiatic scoliosis
    Á°ñ¼º Ãø¸¸(¡­ö°Ø¶).
  • myopathic scoliosis
    ±Ùº´Áõ¼º Ãø¸¸(¡­ö°Ø¶).
  • organic scoliosis
    ±âÁú¼º Ãø¸¸(Áõ) (Ðïòõàõö°Ø¶ñø).
  • paralytic scoliosis
    ¸¶ºñ¼º ôÃßÃø¸¸Áõ(¡­ô±õÏö°Ø¶ñø).
  • rachitic scoliosis
    ±¸·çº´¼º Ãø¸¸( ×§Ü»àõ ö°Ø¶).
  • rachitic scoliosis
    ±¸·çº´¼º Ãø¸¸(±¸×§Ü»àõ ö°Ø¶)
  • rheumatic scoliosis
    ·ù¸¶Æ¼½º Ãø¸¸(¡­ö°Ø¶).
  • rheumatic scoliosis
    ·ù¸¶Æ¼½ºÃø¸¸(¡­ö°Ø¶).
  • rheumatic scoliosis
    ·ù¸¶Æ¼½ºÃø¸¸(¡­ö°Ø¶)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • functional scoliosis
    ±â´É¼ºÃ´ÃßÃø¸¸Áõ
  • scoliosis
    Ãø¸¸Áõ
  • anti-inflammatory
    Ç׿°Áõ¾à, Ç׿°Áõ¼ºÀÇ
  • inflammatory
    ¿°Áõ¼º
  • inflammatory tissue
    ¿°ÁõÁ¶Á÷
  • pelvic inflammatory disease
    °ñ¹Ý¿°Áúȯ
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
JIS Japanese industrial standard; juvenile idiopathic scoliosis
PAIN pyoderma gangrenosum, aphthous stomatitis, inflammatory eye disease, erythema nodosum [disorders ass...
AFP Alpha(¥á) Feto-Protein [HP 1826, 1858, 1859, 2265]
  ; Oncofetal Antigens
 &nbs...
CEA Carcino-Embryonic Antigen [HP 1825-6]
  ; Oncofetal Antigens
  ; Glycopro...
CIDP Chronic Inflammatory Demyelinating Poly(radiculo)neuropathy
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
AIS Adolescent Idiopathic Scoliosis
IS Idiopathic scoliosis
AIDP Acute inflammatory demyelinating polyneuropathy
AIF-1 Allograft Inflammatory Factor-1
CIDP Chronic Inflammatory Demyelinating Neuropathy
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • dorsal scoliosis
    ÈäºÎ Ãø¸¸Áõ
  • habit scoliosis
    ½À°ü¼º Ãø¸¸Áõ, ½À°ü¼º ôÁÖ Ãø¸¸Áõ
  • habitual scoliosis
    ½À°ü¼º Ãø¸¸Áõ, ½À°ü¼º ôÁÖ Ãø¸¸Áõ
  • myopathic scoliosis
    ±Ùº´Áõ¼º Ãø¸¸
  • paralytic scoliosis
    ¸¶ºñ¼º ôÃß Ãø¸¸Áõ
  • rachitic scoliosis
    ±¸·çº´¼º Ãø¸¸
    ±¸·çº´¿¡ ÀÇÇÑ Ã´Ãß ¸¸°î.
  • sciatic scoliosis
    Á°ñ ½Å°æÅ뼺 Ãø¸¸
    ÁÂÀ§³ª ¿ÍÀ§¿¡¼­´Â ¼Ò½Ç, ÀϽÃÀû ¹Ý»ç¼º ±Ù±¸Ãà.
  • acute inflammatory demyelinating polyradiculoneuropathy
    ±Þ¼º ¿°Áõ¼º ´Ù¹ß½Å°æ¿°
    ¾ÆÁ÷µµ È®½ÇÇÏÁö ¾ÊÁö¸¸ ¸é¿ª¹ÝÀÀÀ» ÅëÇÏ¿© ³ªÅ¸³­´Ù°í ¾Ë·ÁÁ® ÀÖ´Â ½Å°æº´ÁõÀÌ´Ù. ÀÓ»óÀûÀ¸·Î´Â ±Þ¼ÓÈ÷ ÁøÇàÇÏ´Â ¿îµ¿½Å°æº´ÁõÀ¸·Î ÇÏÁö¿¡¼­ ½ÃÀÛÇÏ¿© »óÁö·Î ÁøÇàµÇ¸ç, Á¤µµÀÇ Â÷À̸¦ °¡Áø °¨°¢Àå¾Ö¸¦ µ¿¹ÝÇÑ´Ù.
  • anti-inflammatory
    Ç׿°Áõ¾à, Ç׿°ÁõÀÇ, Ç׿°Áõ¼ºÀÇ
    ¿°Áõ¿¡ ¹Ý´ë·Î ÀÛ¿ëÇϰųª ¿°ÁõÀ» ¾ïÁ¦ÇÏ´Â.
  • anti-inflammatory agent
    Ç׿°Áõ ¾à, ¼Ò¿°Á¦, Ç׿°ÁõÁ¦
    ¿°Áõ¿¡ ¹Ý´ë·Î ÀÛ¿ëÇϰųª ¿°ÁõÀ» ¾ïÁ¦ÇÏ´Â ¾àÁ¦.
  • chronic inflammatory trismus
    ¸¸¼º ¿°Áõ¼º ¾Æ°ü±ä±Þ
  • fibrous inflammatory hyperplasia
    ¼¶À¯ ¿°Áõ¼º °úÇü¼º
  • heavier inflammatory component
    ´õ ½ÉÇÑ ¿°Áõ ¿äÀÎ
  • inflammatory
    ¿°Áõ¼º
    ¿°Áõ°ú °ü·ÃµÈ.
  • inflammatory by-product
    ¿°Áõ ºÎ»ê¹°
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
rachitic scoliosis Scoliosis occurring as a result of rickets.
(05 Mar 2000)
paralytic scoliosis Lateral curvature of the spine due to paralysis of spinal muscles.
(05 Mar 2000)
myopathic scoliosis Lateral curvature due to weakness of the spinal muscles, as in poliomyelitis.
(05 Mar 2000)
coxitic scoliosis Scoliosis in the lumbar spine resulting from tilting of the pelvis in a case of hip disease.
(05 Mar 2000)
habit scoliosis Scoliosis supposedly due to habitual standing or sitting in an improper position.
(05 Mar 2000)
sciatic scoliosis Scoliosis caused by asymmetric spasm of spinal muscles usually associated with sciatica, usually presenting as a list toward one side.
(05 Mar 2000)
scoliosis <anatomy> A congenital lateral curvature of the spine.
(27 Sep 1997)
static scoliosis Lateral curvature of the spine due to inequality in length of the legs.
(05 Mar 2000)
ocular scoliosis Scoliosis supposed to be due to head tilting, caused by ophthalmological dysfunction.
(05 Mar 2000)
osteopathic scoliosis Lateral curvature of the spine due to vertebral disease.
(05 Mar 2000)
empyaemic scoliosis Scoliosis due to retraction of one side of the chest following an empyema.
(05 Mar 2000)
acute inflammatory polyneuropathy <neurology, syndrome> Acute infective polyneuritis that results in a form of peripheral neuropathy with temporary loss of movement and sensation due to inflammation of multiple nerves and loss of myelin.
The exact cause is unknown but has been associated with an abnormal immune response to viral infection, particularly cytomegalovirus infection, in which there is cell-mediated immunity to a component of myelin. The disease may be autoimmune in origin and complete recovery can take up to six months.
Synonym: Guillain-Barre syndrome
(12 Jul 2000)
anti-inflammatory Counteracting or suppressing inflammation.
(18 Nov 1997)
anti-inflammatory agent Agents that counteract or suppress the inflammatory process. An antirheumatic agent or inflammation mediator, both endogenous and exogenous substances used to counteract the inflammatory process or alleviate or prevent rheumatic diseases, and the compounds that mediate the inflammation process.
(12 Dec 1998)
anti-inflammatory agent, non-steroidal Anti-inflammatory agents that are not steroids. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They are used primarily in the treatment of chronic arthritic conditions and certain soft tissue disorders associated with pain and inflammation. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. Certain nsaids also may inhibit lipoxygenase enzymes or phospholipase c or may modulate T-cell function. (ama drug evaluations annual, 1994, p 1814-5)
(12 Dec 1998)
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
inflammatory scoliosis Scoliosis due to disease of the vertebrae.
Ãâó:
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • scoliosis
    ôÃß Ãø°î(ôÃß°¡ ¿ÞÂÊ ¶Ç´Â ¾î¸¥ÂÊÀ¸·Î ±Á´Â º´
  • inflammatory
    ¼±µ¿ÀûÀÎ
  • inflammatory
    ¿°ÁõÀ» ÀÏÀ¸Å°´Â;¿°Áõ¼ºÀÇ;°Ý¾Ó½ÃŰ´Â;¼±µ¿ÀûÀÎ
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á